PFBT
TARS icon

Parkside Financial Bank & Trust’s Tarsus Pharmaceuticals TARS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48K Hold
87
– – ﹤0.01% 1867
2026
Q1 		$6.1K Buy
87
+71
+444% +$4.96K ﹤0.01% 1756
2025
Q4 		$1.31K Hold
16
– – ﹤0.01% 2245
2025
Q3 		$951 Buy
16
+15
+1,500% +$738 ﹤0.01% 2303
2025
Q2 		$41 Sell
1
-9
-90% -$405 ﹤0.01% 2708
2025
Q1 		$515 Buy
+10
New +$494 ﹤0.01% 2365

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parkside Financial Bank & Trust's TARS Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 87 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Parkside Financial Bank & Trust first reported a position in TARS in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.1K in Q1 2026. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Parkside Financial Bank & Trust held 87 shares of Tarsus Pharmaceuticals worth $5.48K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1867 holding.
  • Parkside Financial Bank & Trust first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's Tarsus Pharmaceuticals position peaked at $6.1K in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.